A Nomogram to Preoperatively Predict the Aggressiveness of Pancreatic Neuroendocrine Tumors Based on CT Features and 3D CT Radiomic Features

Overview

Journal Abdom Radiol (NY)

Publisher Springer

Date 2025 Jan 22

PMID 39841226

Authors

Ziyao Wang

Jiajun Qiu

Xiaoding Shen

Fan Yang

Xubao Liu

Xing Wang

Nengwen Ke

Affiliations

Soon will be listed here.

Abstract

Objectives: Combining Computed Tomography (CT) intuitive anatomical features with Three-Dimensional (3D) CT multimodal radiomic imaging features to construct a model for assessing the aggressiveness of pancreatic neuroendocrine tumors (pNETs) prior to surgery.

Methods: This study involved 242 patients, randomly assigned to training (170) and validation (72) cohorts. Preoperative CT and 3D CT radiomic features were used to develop a model predicting pNETs aggressiveness. The aggressiveness of pNETs was characterized by a combination of factors including G3 grade, nodal involvement (N + status), presence of distant metastases, and/or recurrence of the disease.

Results: Three distinct predictive models were constructed to evaluate the aggressiveness of pNETs using CT features, 3D CT radiomic features, and their combination. The combined model demonstrated the greatest predictive accuracy and clinical applicability in both the training and validation sets (AUCs (95% CIs) = 0.93 (0.90-0.97) and 0.89 (0.79-0.98), respectively). Subsequently, a nomogram was developed using the features from the combined model, displaying strong alignment between actual observations and predictions as indicated by the calibration curves. Using a nomogram score of 86.06, patients were classified into high- and low-aggressiveness groups, with the high-aggressiveness group demonstrating poorer overall survival and shorter disease-free survival.

Conclusion: This study presents a combined model incorporating CT and 3D CT radiomic features, which accurately predicts the aggressiveness of PNETs preoperatively.

References

Hashim Y, Trinkaus K, Linehan D, Strasberg S, Fields R, Cao D . Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2013; 259(2):197-203. PMC: 4164305. DOI: 10.1097/SLA.0000000000000348. View

Liang W, Yang P, Huang R, Xu L, Wang J, Liu W . A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clin Cancer Res. 2018; 25(2):584-594. DOI: 10.1158/1078-0432.CCR-18-1305. View

Bolm L, Nebbia M, Wei A, Zureikat A, Fernandez-Del Castillo C, Zheng J . Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort. Ann Surg. 2022; 276(3):522-531. PMC: 9388557. DOI: 10.1097/SLA.0000000000005559. View

Rebours V, Cordova J, Couvelard A, Fabre M, Palazzo L, Vullierme M . Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?. Dig Liver Dis. 2015; 47(11):973-7. DOI: 10.1016/j.dld.2015.06.005. View

Fujimori N, Osoegawa T, Lee L, Tachibana Y, Aso A, Kubo H . Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol. 2015; 51(2):245-52. DOI: 10.3109/00365521.2015.1083050. View

Chen H, Pan Y, Chen J, Liu L, Yang Y, Li K . Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas. Eur Radiol. 2022; 32(12):8317-8325. DOI: 10.1007/s00330-022-08891-4. View

Li Y, Deng W, Zhou Y, Luo Y, Wu Y, Wen J . A nomogram based on clinical factors and CT radiomics for predicting anti-MDA5+ DM complicated by RP-ILD. Rheumatology (Oxford). 2023; 63(3):809-816. DOI: 10.1093/rheumatology/kead263. View

Kerr K, Brown M, Zhu K, Janes H . Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use. J Clin Oncol. 2016; 34(21):2534-40. PMC: 4962736. DOI: 10.1200/JCO.2015.65.5654. View

Gu D, Hu Y, Ding H, Wei J, Chen K, Liu H . CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur Radiol. 2019; 29(12):6880-6890. DOI: 10.1007/s00330-019-06176-x. View

10.

Ye J, Fang P, Peng Z, Huang X, Xie J, Yin X . A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors. Eur Radiol. 2023; 34(3):1994-2005. PMC: 10873440. DOI: 10.1007/s00330-023-10186-1. View

11.

Meng L, Dong D, Chen X, Fang M, Wang R, Li J . 2D and 3D CT Radiomic Features Performance Comparison in Characterization of Gastric Cancer: A Multi-Center Study. IEEE J Biomed Health Inform. 2020; 25(3):755-763. DOI: 10.1109/JBHI.2020.3002805. View

12.

Alhussaini A, Douglas Steele J, Nabi G . Comparative Analysis for the Distinction of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma in Computed Tomography Imaging Using Machine Learning Radiomics Analysis. Cancers (Basel). 2022; 14(15). PMC: 9332006. DOI: 10.3390/cancers14153609. View

13.

Maggino L, Schmidt A, Kading A, Westermark S, Ceppa E, Falconi M . Reappraisal of a 2-Cm Cut-off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study. Ann Surg. 2019; 273(5):973-981. DOI: 10.1097/SLA.0000000000003508. View

14.

Shen X, Yang F, Jiang T, Zheng Z, Chen Y, Tan C . A nomogram to preoperatively predict the aggressiveness of non-functional pancreatic neuroendocrine tumors based on CT features. Eur J Radiol. 2024; 171:111284. DOI: 10.1016/j.ejrad.2023.111284. View

15.

Nagtegaal I, Odze R, Klimstra D, Paradis V, Rugge M, Schirmacher P . The 2019 WHO classification of tumours of the digestive system. Histopathology. 2019; 76(2):182-188. PMC: 7003895. DOI: 10.1111/his.13975. View

16.

Ren S, Qian L, Daniels M, Duan S, Chen R, Wang Z . Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis. Eur J Radiol. 2020; 133:109360. DOI: 10.1016/j.ejrad.2020.109360. View

17.

Canellas R, Burk K, Parakh A, Sahani D . Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis. AJR Am J Roentgenol. 2017; 210(2):341-346. DOI: 10.2214/AJR.17.18417. View

18.

Hyodo R, Suzuki K, Ogawa H, Komada T, Naganawa S . Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading. Eur J Radiol. 2015; 84(11):2103-9. DOI: 10.1016/j.ejrad.2015.08.014. View

19.

Jeon S, Lee J, Joo I, Lee E, Park H, Jang J . Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study. Radiology. 2017; 284(1):77-87. DOI: 10.1148/radiol.2016160586. View

20.

Li D, Peng Q, Wang L, Cai W, Liang M, Liu S . Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9. Eur Radiol. 2023; 34(1):509-524. DOI: 10.1007/s00330-023-09980-8. View